Singapore: +65-31631880 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Kenya: +254-732-300719

          

Advanced PG Diploma in Clinical Research &
Pharmacovigilance

Pharmacovigilance Training in Singapore | Online Pharmacovigilance Course | Drug Safety

Pharmacovigilance Training in Singapore | Online Pharmacovigilance Course | Drug Safety


The industry of pharmaceutical and biotech specialization is undergoing great changes in a way, which allows innovation and pharmacovigilance to not be polarized. Almost all contemporary business models are changing into a new level of niche-concentration with a coexistence of new and old strategies.

Pharmacovigilance plays a vital part in product life cycle, as there is great demand carried through for new drugs and their regulations.

Since there is a great drift in the economies of emerging countries like India, China, Brazil and Russia, the industry is changing the aim of R&D towards these areas, exclusively when it comes to the phases of clinical development.

There are a great number of multinational companies, which include names like Pfizer and Novartis, which have opened pharmacovigilance centers in some of the many major clinical research hubs around the world, a good example of which is India.


In Singapore, the year 1993 witnessed the formation of a Pharmacovigilance Branch. Although it did exist previously, it was referred to as the Adverse Drug Reaction Monitoring Unit (ADRMU). A year later i.e. in 1994 the Pharmacovigilance Branch became a part of the WHO International Drug Monitoring Programme for international collaboration on drug safety as its 40th member. Since its formation, the primary objective of the branch has been to act as a national centre for assembling all information related to drug safety in a written manner and to review reports of adverse drug reaction received from various sources such as medical practitioners, drug companies and other government agencies.

To keep pace with the growth of the pharmaceutical sector since 1993, it became important for the Pharmacovigilance Branch to keep reviewing and expanding its safety monitoring activities. In 2009, this led to another name change of the Pharmacovigilance Branch after it included vaccines and novel drugs under its purview as well. The branch has been known as the ‘Vigilance Branch’ since then. The name change or the expansion of the Branch has not affected any of the underlying principles of safety monitoring and risk assessment.

The Health Sciences Authority (HSA) of Singapore has put in place a Product Vigilance Advisory Committee (PVAC) to evaluate the overall effect of safety issues related to the main healthcare commodities and to guide HSA on the possible legal actions to be taken to improve the safety of healthcare commodities.

When a much broader economic platform is taken into consideration, there are a great number of clinical research management organizations to be found, which have proceeded with the development of a great range of full service CROs, early phase CROs, SMOs, and different companies with specialized services. This has naturally increased the demand for a skilled workforce in this field of operations.


The James Lind Institute places its commitment in developing aspiring professionals for the industry, who must be equipped with the most vital and up-to-date knowledge and expertise.


The APGDCR-P course aims to provide candidates with a great understanding of the main areas in clinical research processes and pharmacovigilance methodologies, therefore targeting and enhancement in skills and knowledge, which are to be expected of a professional in Clinical Research and Pharmacovigilance. The course does not only teach skills in clinical research management, it also pays huge attention to training the students to collate, analyze and archive different reaction data for drugs, which will in turn help make regulatory decisions, which are related to marketed drugs. These sectors are both opening up a huge amount of job opportunities at the moment.


The clinical research industry and the academia have completely reviewed and approved the APGDCR-P course curriculum, in order to provide aspiring students with the edge required to enter the industry. It also teaches a selected set of skills and knowledge, which prove to be useful for moving forward in the echelons of the management hierarchy.



program curriculum

Towards the end of the program mock exercises and role plays may be conducted for relevant topics that guide students about handling on-job situations commonly faced by clinical research professionals.


Program duration


Self Paced 6 - 8 months (Maximum duration 24 months)

All individuals participating in the program Advanced Post Graduate Diploma in Clinical Research & Pharmacovigilance (APGDCR-P) are required to invest about 15 hours every week in their online studies.


Program Assessment


Participants are assessed via an ongoing evaluation approach by the faculty. There is no single final completion exam. Participants are assessed based on the following:

Completion of online Multiple Choice Question tests for every lesson studied and ongoing submission of project work for each module.



The minimum eligibility criteria for Advanced Post-Graduate Diploma in Clinical Research & Pharmacovigilance (APGDCR-P) would include either of the following:

  • Any degree in Bioscience/Life Sciences such as Biochemistry, Microbiology, Genetics, Biotechnology, Botany, Zoology etc

  • Any degree in Medicine such as MBBS, BDS, BPT, BAMS, BHMS,, BUMS etc

  • Any degree in Pharmacy / Pharmaceutical Sciences

  • Any degree in Chemistry / Biostatistics / Bioinformatics

  • Any degree in Nursing / Allied Health.

  • Students in their final year of graduation for the above courses are also eligible to apply.


  • If you do not possess the qualifications mentioned above you may still be eligible to apply based on any prior relevant work experience and upon recommendation of your line manager. Please contact our admission team / counsellor for more information.


Program Fee


JLI has been globally acknowledged for its determination to provide economical yet high quality training programs to aspirants. You may use our Online Program Fee Calculator below to determine the tuition fee applicable to you for the current academic year.



Should your country not be available in the calculator or should you not be able to figure out the tuition fee that applies to you for this online training program please send an email enquiry to admissions@jli.sg or contact the online chat support available on this website.

To know more regarding the application procedure please click here.


Program Support


Each participant enrolled in APGDCR-P is in close contact with a mentor throughout the program. The mentor is an industry expert working in a senior leadership position. The mentor can be approached at any time via email or phone. Participants can also communicate with peers and faculty via their study accounts to discuss any topic or question.

Upon completion of the program students are provided placement guidance and support for career development via the “Student Success Team (SST)”. To know more about the SST, please click here.



James Lind Institute Newsletter
James Lind Institute Youtube
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Facebook